Short answer: Peptide mapping is a way of checking a protein's or large peptide's primary structure by cutting it into a predictable set of smaller peptides and separating them. In the wording of the ICH Q6B guideline, the product is selectively fragmented into discrete peptides using suitable enzymes or chemicals, the fragments are analyzed by HPLC or another appropriate procedure, and they are identified to the extent possible by amino acid analysis, N-terminal sequencing or mass spectrometry [1]. Because the map is sensitive to even small changes in covalent structure, it works as a "fingerprint" for identity testing and process monitoring [9].
This article is educational analytical chemistry for laboratory readers. It does not describe effects in people or animals and is not guidance for human or animal use.
Where peptide mapping sits in quality testing
ICH Q6B, the ICH harmonised guideline on specifications for biotechnological and biological products, lists the peptide map under structural characterization and confirmation, alongside amino acid sequence and terminal amino acid analysis [1]. It notes that peptide mapping of the drug substance or drug product with an appropriately validated procedure is frequently used to confirm the desired product structure for lot release [1].
The same guideline describes identity tests as needing to be highly specific and based on unique aspects of a molecule's structure, and it allows characterization methods to be used or adapted for that purpose [1]. One validation paper put the link directly: the map's sensitivity to even the smallest change in covalent structure is what makes it a valuable fingerprint for identity testing [9].
The basic workflow
A 2022 review of peptide mapping by capillary electromigration methods breaks the process into five main aspects [14]:
- Pre-cleavage preparation: purification, preconcentration, denaturation, and reduction and alkylation of the protein.
- Cleavage: generating peptide fragments by enzymatic and/or chemical cleavage, off-line or on-line.
- Post-cleavage preparation of the peptide mixture.
- Separation of the complex peptide mixture, in that review's case by capillary electromigration methods coupled with mass spectrometry.
- Applications, such as qualitative analysis of monoclonal antibodies and other protein biopharmaceuticals and monitoring of post-translational modifications.
Choosing the "scissors": enzymes and their rules
Q6B calls for selective fragmentation into discrete peptides [1], so the reagent's cleavage rules shape the whole map. (Our peptide hydrolysis guide covers the chemistry of breaking peptide bonds in general.)
- Trypsin. Trypsin catalyzes hydrolysis only at the carboxyl side of the basic amino acids arginine and lysine [2]. A high-mass-accuracy study concluded that trypsin cleaves solely C-terminal to arginine and lysine, and that the non-tryptic peptides it saw were C-terminal peptides of proteins or breakup products of tryptic peptides N-terminal to an internal proline [3].
- The proline question. The generally accepted "Keil rule" says trypsin cleaves next to arginine or lysine but not before proline [4]. A re-analysis of 14.5 million tandem mass spectra found a surprisingly large number of cleavages before proline, and its authors argued that search software should allow them [4].
- Missed cleavages. For trypsin, Lys-C and Lys-N, the most broadly used proteomics enzymes, whether a site is cut or missed can be predicted from the side chains within 15 residues of it; proline, negatively charged side chains and phosphorylated residues all have measurable effects [5].
- Chymotrypsin. Chymotrypsin cleaves only at the carboxyl side of the aryl-substituted amino acids phenylalanine, tyrosine and tryptophan [2].
- Glu-C (staphylococcal V8 protease). In phosphate buffer at pH 7.8 this enzyme cleaves on the carboxyl side of aspartate or glutamate, but in ammonium bicarbonate (pH 7.8) or ammonium acetate (pH 4.0) it hydrolyzes only glutamoyl bonds; of the aspartoyl bonds tested, only Asp-Gly was cut at a detectable rate [6]. The buffer, in other words, is part of the method.
- Asp-N. Asp-N is specific for bonds N-terminal to aspartate or cysteic acid, but one study found it also cut 5 of 18 glutamate residues in two protein fragments at rates comparable to its aspartate sites [7].
What a peptide map can reveal
Once the fragments are identified, differences from the expected map point to specific structural features. In biopharmaceutical development, LC-MS/MS peptide mapping has been applied to product heterogeneity from multiple N- or C-termini, deamidation, oxidation and glycosylation, and to protein degradation [8]. (See our guides to deamidation and methionine oxidation for what those modifications are chemically.)
Disulfide bonds need a variation. ICH Q6B says that when cysteine residues are expected from the gene sequence, the number and positions of free sulfhydryl groups and disulfide bridges should be determined where possible, and that peptide mapping under reducing and non-reducing conditions can help [1]. Non-reduced peptide mapping by LC-MS is a commonly used method for characterizing disulfide linkages [12]. (Our disulfide bond guide explains the linkage itself.)
The approach has also been extended into a single quantitative assay. Amgen scientists described a mass spectrometry "multi-attribute method" (MAM) that uses high-resolution, high-mass-accuracy data and automated software to identify and relatively quantify many product quality attributes at once, with the potential to replace several conventional electrophoretic and chromatographic QC methods [13].
Artifacts: when the method changes the sample
Peptide mapping can create some of the modifications it is meant to measure.
- Digestion time and pH. Trypsin digestion can induce asparagine deamidation and N-terminal glutamine cyclization because of the temperature and alkaline buffers used, and the amount of these artifacts is directly proportional to incubation time [10]. By removing guanidine, a known trypsin inhibitor, from the digestion buffer, one group achieved near-complete digestion of reduced and alkylated antibodies in 30 minutes, with little protocol-induced deamidation or glutamine cyclization and cleaner tryptic maps [10].
- Overnight versus fast digests. Digests incubated for hours to overnight often induce artifacts such as deamidation and isomerization, leading to overestimated modification levels, but simply shortening digestion can cause incomplete cleavage, low sequence coverage and poor repeatability [11]. A 0.5-hour pressure-cycling tryptic digest minimized modification artifacts compared with 4-hour and 18-hour conventional digests at 37 °C [11].
- Disulfide scrambling. In non-reduced mapping, basic pH and high temperature during denaturation and digestion can scramble disulfide bonds, while acidic conditions increase missed and non-specific cleavages because most enzymes work best at alkaline pH [12]. Adding the oxidizing agent cystamine plus a low concentration of iodoacetamide significantly reduced scrambled peptides at basic pH in that study [12].
Reproducibility and validation
A peptide map used for identity has to look the same run after run. Validation work on an RP-HPLC tryptic map noted that a key difficulty is the lack of proper quantitative measures of reproducibility, and used principal component analysis of whole maps to summarize precision, ruggedness and robustness studies and to troubleshoot problems [9]. The LC-MS validation study likewise evaluated and optimized each step, described validation of a single-quadrupole MS detector, and used on-line electrospray MS as an adjunct detector to investigate peak differences [8].
How it relates to other peptide tests
ICH Q6B lists it alongside terminal amino acid analysis and amino acid sequencing within structural characterization, and separately notes that purity is usually estimated with a combination of methods [1]. For background on the individual techniques, see our guides to Edman degradation, mass spectrometry testing and HPLC peptide testing.
FAQ
What is peptide mapping?
Selective fragmentation of a protein or large peptide into discrete peptides with enzymes or chemicals, followed by separation (usually HPLC) and identification of the fragments [1].
Why is trypsin used so often?
Almost all large-scale mass spectrometry proteomics projects use it [3], and it cuts at the carboxyl side of arginine and lysine [2][3].
Does trypsin cut before proline?
The classic Keil rule says no, but a large mass spectrometry re-analysis found many cleavages before proline [4].
What is a non-reduced peptide map?
A map made under non-reducing conditions, used to characterize disulfide linkages; ICH Q6B mentions mapping under both reducing and non-reducing conditions for locating disulfide bridges [1][12].
Can sample preparation distort the results?
Yes. Long, alkaline, warm digestions can create deamidation, isomerization and glutamine cyclization artifacts, which faster digestion methods reduce [10][11].
Bottom line
A peptide map turns one large molecule into a fingerprint of predictable fragments [1][9]. The enzyme's cleavage rules [2][3][4][6] decide what that fingerprint looks like, LC-MS identifies the pieces and their modifications [8][13], and careful sample preparation keeps the method from adding artifacts of its own [10][11][12].
All products are for research use only — not for human or animal consumption.